Literature DB >> 318580

Effect of deoxycholic acid ingestion on bile acid metabolism and biliary lipid secretion in normal subjects.

N F LaRusso, P A Szczepanik, A F Hofmann.   

Abstract

The effect of deoxycholate ingestion, 750 mg per day, on bile acid kinetics, biliary bile acid composition, and biliary lipid secretion was studied in 7 healthy volunteers. Bile acid kinetics were measured by isotope dilution, and hourly outputs of bile acid, cholesterol, and phospholipid were quantitated by a duodenal perfusion technique during a 24-hr period which included three liquid meals and an overnight fast. Biliary bile acid composition was assessed by coupled gas chromatography-mass spectrometry. After deoxycholic acid ingestion, biliary bile acids became composed of predominantly deoxycholyl conjugates, and deoxycholic acid pools increased 4-fold. Both chenodeoxycholic and cholic acid pools decreased, and daily synthesis of each of the primary bile acids was inhibited by 50%. Total bile acid pools did not change in any consistent manner. Daily bile acid secretion increased slightly during deoxycholic acid ingestion, and recycling frequency varied reciprocally with the total bile acid pool both before and during deoxycholic acid treatment. Deoxycholic acid ingestion caused no change in either the daily secretion of cholesterol or lecithin, or the cholesterol saturation of fasting-state bile, which remained unsaturated throughout the study. SGOT levels increased to 4 times the upper limits of normal in 2 of 7 subjects, but these levels promptly returned to normal when deoxycholate feeding was stopped. Serum cholesterol levels decreased in every subject (average 15%) during deoxycholic acid administration. No evidence for a direct role of deoxycholate in the pathogenesis of cholesterol cholelithiasis was obtained in these studies.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 318580

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  21 in total

1.  Patients, cells, and organelles: the intersection of science and serendipity.

Authors:  Nicholas F Larusso
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

2.  Gallstone prevalence and biliary lipid composition in inflammatory bowel disease.

Authors:  J W Marks; D R Conley; T L Capretta; G G Bonorris; A Chung; M J Coyne; L J Schoenfield
Journal:  Am J Dig Dis       Date:  1977-12

Review 3.  Deoxycholic acid and the pathogenesis of gall stones.

Authors:  S N Marcus; K W Heaton
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

4.  Increased deoxycholic acid absorption and gall stones in acromegalic patients treated with octreotide: more evidence for a connection between slow transit constipation and gall stones.

Authors:  A F Hofmann
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

5.  Treatment with bile acids.

Authors: 
Journal:  Br Med J       Date:  1978-07-29

6.  Effect of a combination of gastrin, secretin, cholecystokinin, glucagon, and gastric inhibitory polypeptide on jejunal absorption in man.

Authors:  P Poitras; R Modigliani; J J Bernier
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

7.  Role of primary and secondary bile acids as feedback inhibitors of bile acid synthesis in the rat in vivo.

Authors:  E F Stange; J Scheibner; H Ditschuneit
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

8.  [Relation between serum lipoprotein metabolism and biliary lipid metabolism].

Authors:  O Leiss; K von Bergmann
Journal:  Klin Wochenschr       Date:  1983-06-15

9.  Gallbladder and small intestinal regulation of biliary lipid secretion during intraduodenal infusion of standard stimuli.

Authors:  G T Everson; M J Lawson; C McKinley; R Showalter; F Kern
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

10.  Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis.

Authors:  P Di Donato; F Carubbi; M Ponz de Leon; N Carulli
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.